RNS Announcements

2023

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, announces that the Company has 158,166,666 ordinary shares of 0.05p each in issue (“Ordinary Shares”), each share carrying the right to one vote.

This figure of 158,166,666 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:

2022

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, announces that the Company has 158,166,666 ordinary shares of 0.05p each in issue (“Ordinary Shares”), each share carrying the right to one vote.

This figure of 158,166,666 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact: